Dow Surges 150 Points; Crude Oil Falls Sharply

U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Monday.

The Dow traded up 0.45% to 33,898.95 while the NASDAQ rose 0.11% to 11,335.52. The S&P 500 also rose, gaining, 0.30% to 4,004.81.

Also check this: Investor Sentiment Increases After S&P 500 Records Best Week Since June


Leading and Lagging Sectors


Health care shares jumped 1% on Monday. Leading the sector was strength from PDS Biotechnology Corporation. PDSB and Monte Rosa Therapeutics, Inc. GLUE.


In trading on Monday, real estate shares dipped by 1.2%.


Top Headline

 

Tyson Foods, Inc. TSN reported mixed results for its fourth quarter on Monday.

Tyson Foods reported fourth-quarter FY22 sales growth of 7.2% year-on-year to $13.74 billion, beating the consensus of $13.49 billion. Adjusted EPS of $1.63 missed the analyst consensus of $1.73.

Tyson Foods expects FY23 sales of $55 billion - $57 billion, versus the consensus of $53.61 billion. It sees FY23 capital expenditure of $2.5 billion.

 


Equities Trading UP

 

  • Opiant Pharmaceuticals, Inc. OPNT shares shot up 115% to $20.23. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus contingent value rights (CVRs) of up to $8.00 per share.
  • Shares of Freight Technologies, Inc. FRGT got a boost, shooting 127% to $0.4690 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.
  • ToughBuilt Industries, Inc. TBLT shares were also up, gaining 58% to $3.4807 after the company reported better-than-expected Q3 EPS results.


Equities Trading DOWN

  • Satsuma Pharmaceuticals, Inc. STSA shares tumbled 84% to $0.66 after the company reported topline results from the STS101 SUMMIT Phase 3 efficacy trial in migraine patients.
  • Shares of SELLAS Life Sciences Group, Inc. SLS were down 42% to $2.64 after the company reported Q3 earnings results and provided a business update.
  • POINT Biopharma Global Inc. PNT was down, falling 35% to $5.95. Lantheus and POINT Biopharma announced collaboration and exclusive license agreements for commercialization of PNT2002 & PNT2003.


Also check out: Unity Software, Amazon, Doximity And Other Big Gainers From Friday


Commodities

In commodity news, oil traded down 3.5% to $85.83 while gold traded up 0.3% at $1,774.80.


Silver traded up 2% to $22.11 on Monday while copper fell 1.9% to $3.8395.


Euro zone


European shares were higher today. The eurozone’s STOXX 600 gained 0.14%, London’s FTSE 100 rose 0.92% while Spain’s IBEX 35 Index rose 0.84%. The German DAX climbed 0.62%, French CAC 40 rose 0.22% and Italy’s FTSE MIB Index gained 0.58%.


Industrial production in the Eurozone increased 0.9% from a month ago in September versus a revised 2.0% increase in the previous month.

 

Asia Pacific Markets


Asian markets closed mixed on Monday, with the Japan’s Nikkei dropping 1.06% and Hong Kong’s Hang Seng Index gaining 1.7%. China’s Shanghai Composite Index slipped 0.13%.

The annual wholesale price inflation rate in India eased to 8.39% in October from 10.7% percent in the earlier month, while total passenger vehicles sales in the country fell by 5.4% percent month-over-month to 291,113 units during October.


Economics


Federal Reserve Bank of New York President John Williams is set to speak at 6:30 p.m. ET.


Check out this: Volatility In Markets Eases Further As US Stocks Extend Gains


COVID-19 Update

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 99,898,460 cases with around 1,100,120 deaths. India confirmed a total of at least 44,666,920 cases and 530,530 deaths, while France reported over 37,127,170 COVID-19 cases with 157,700 deaths. In total, there were at least 640,440,610 cases of COVID-19 worldwide with more than 6,615,720 deaths.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!